Virtual Medicinal Product (VMP) - Satralizumab 120mg/1ml solution for injection pre-filled syringes
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Satralizumab 120mg/1ml solution for injection pre-filled syringes | Start Date 07-02-2024 | End Date |
| Abbreviated Name | Abbreviated Name Satralizumab 120mg/1ml inj pre-filled syringes | Start Date 07-02-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AC19
- BNF Codes
-
- BNF code 08020400
| Code | Start Date | End Date |
|---|---|---|
| 42626811000001106 | 07-02-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Satralizumab | Based on Ingredient Substance | 120 mg | 1 ml |
Name
Satralizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
120.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMSatralizumab
-
VMP(Current) Satralizumab 120mg/1ml solution for ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 pre-filled disposable injection |